Message from the Chair
Make a Gift
A gift to the Dept of Surgery
helps us discover new
treatments and cures.
In Memoriam
Dr. Alfred de Lorimier, a pioneer in pediatric surgery and the founder of the Division of Pediatric Surgery at UCSF, has passed away.
Department of Surgery Clinical Trials
Listed below are UCSF clinical trials grouped by conditions and treatments that are applicable to UCSF Department of Surgery patients. Trials are led by Principal Investigators from both the Department of Surgery, and other multidisciplinary programs at UCSF. Each trial includes a biography of the Principal Investigator and contact information for patients interested in enrolling.
Anal Cancer
Cisplatin, Fluorouracil, Cetuximab, and Radiation Therapy in Treating Patients With HIV and Stage I, Stage II, or Stage III Anal Cancer
Study ID: AMC-045
Principal Investigator:
Andrew H. Ko, M.D.
Andrew H. Ko, M.D.
Recruiting
Aortic Aneurysms
Bifurcated Stent-Graft for Endovascular Repair of Aneurysms Involving the Proximal Aortic Arch
Study ID: H9065-28979
Principal Investigator:
Timothy A. M. Chuter, M.D.
Timothy A. M. Chuter, M.D.
Recruiting
Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm
Study ID: H5357-26067
Principal Investigator:
Linda M. Reilly, M.D.
Linda M. Reilly, M.D.
Recruiting
Principal Investigator:
Linda M. Reilly, M.D.
Linda M. Reilly, M.D.
Recruiting
Principal Investigator:
Jade S. Hiramoto, M.D.
Jade S. Hiramoto, M.D.
Recruiting
Principal Investigator:
Timothy A. M. Chuter, M.D.
Timothy A. M. Chuter, M.D.
Recruiting
Zenith(R) Fenestrated Abdominal Aortic Aneurysm (AAA) Endovascular Graft Clinical Study
Study ID: H9146-25242
Principal Investigator:
Darren Schneider, M.D.
Darren Schneider, M.D.
Recruiting
Principal Investigator:
Linda M. Reilly, M.D.
Linda M. Reilly, M.D.
Recruiting
Principal Investigator:
Linda M. Reilly, M.D.
Linda M. Reilly, M.D.
Recruiting
Biliary Cancer (Bile Duct & Gallbladder)
Gemcitabine and Capecitabine to Treat Patients With Advanced Pancreatic and Biliary Cancers
Study ID: UCSF-074510
Principal Investigator:
Andrew H. Ko, M.D.
Andrew H. Ko, M.D.
Recruiting
Carotid Artery Disease
Principal Investigator:
Darren Schneider, M.D.
Darren Schneider, M.D.
Recruiting
SAPPHIRE -The Use of Stenting and Angioplasty for Treatment of Carotid Artery Disease
Study ID: H914631429
Principal Investigator:
Darren Schneider, M.D.
Darren Schneider, M.D.
Recruiting
Colon Cancer
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
Study ID: CALGB-C80405
Principal Investigator:
Alan P. Venook, M.D.
Alan P. Venook, M.D.
Recruiting
Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
Study ID: CTSU NCCTG-N0147
Principal Investigator:
Alan P. Venook, M.D.
Alan P. Venook, M.D.
Recruiting
Constipation
Principal Investigator:
Madhulika Varma, M.D.
Madhulika Varma, M.D.
Completed
Principal Investigator:
Madhulika Varma, M.D.
Madhulika Varma, M.D.
Completed
Principal Investigator:
Madhulika Varma, M.D.
Madhulika Varma, M.D.
Completed
Esophageal Cancer
Chemotherapy & Erlotinib in Treating Patients w/ Esophageal or Gastroesophageal Cancer That Cannot Be Removed by Surgery
Study ID: UCSF-064511
Principal Investigator:
W. Michael Korn, MD
W. Michael Korn, MD
Recruiting
Fecal Incontinence
A Randomized, Blinded, Multicenter Study to Evaluate NASHA/Dx for the Treatment of Fecal Incontinence
Study ID: QMED
Principal Investigator:
Madhulika Varma, M.D.
Madhulika Varma, M.D.
Active, but not currently recruiting
A Randomized, Blinded, Multicenter Study to Evaluate NASHA/Dx for the Treatment of Fecal Incontinence
Study ID: QMED
Principal Investigator:
Madhulika Varma, M.D.
Madhulika Varma, M.D.
Active, but not currently recruiting
Gastric Cancer
A Study of Telatinib in Combination With Chemotherapy in Subjects With Advanced Gastric Cancer
Study ID: TEL0805
Principal Investigator:
Andrew H. Ko, M.D.
Andrew H. Ko, M.D.
Recruiting
A Study of Telatinib in Combination With Chemotherapy in Subjects With Advanced Gastric Cancer
Study ID: TEL0805
Principal Investigator:
Andrew H. Ko, M.D.
Andrew H. Ko, M.D.
Recruiting
Islet Cell Transplant
Principal Investigator:
Andrew M. Posselt, M.D., Ph.D.
Andrew M. Posselt, M.D., Ph.D.
Recruiting
Principal Investigator:
Andrew M. Posselt, M.D., Ph.D.
Andrew M. Posselt, M.D., Ph.D.
Recruiting
Principal Investigator:
Andrew M. Posselt, M.D., Ph.D.
Andrew M. Posselt, M.D., Ph.D.
Recruiting
Principal Investigator:
Andrew M. Posselt, M.D., Ph.D.
Andrew M. Posselt, M.D., Ph.D.
Recruiting
Principal Investigator:
Andrew M. Posselt, M.D., Ph.D.
Andrew M. Posselt, M.D., Ph.D.
Recruiting
Principal Investigator:
Andrew M. Posselt, M.D., Ph.D.
Andrew M. Posselt, M.D., Ph.D.
Recruiting
Kidney Transplant
A Dose Escalation and Safety Study of I5NP to Prevent Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation, Part A
Study ID: QRK.006 (Quark)
Principal Investigator:
Sandy Feng, M.D., Ph.D.
Sandy Feng, M.D., Ph.D.
Recruiting
A Phase II Study of Belatacept (BMS-224818) With a Steroid-free Regimen in Subjects Undergoing Kidney Transplantation
Study ID: IM103034
Principal Investigator:
Flavio Vincenti, M.D.
Flavio Vincenti, M.D.
Active, but closed to enrollment
Principal Investigator:
Flavio Vincenti, M.D.
Flavio Vincenti, M.D.
Active, but closed to enrollment
Principal Investigator:
Stephen J. Tomlanovich, M.D.
Stephen J. Tomlanovich, M.D.
Recruiting
Principal Investigator:
Stephen J. Tomlanovich, M.D.
Stephen J. Tomlanovich, M.D.
Recruiting
Principal Investigator:
Stephen J. Tomlanovich, M.D.
Stephen J. Tomlanovich, M.D.
Recruiting
Principal Investigator:
Stephen J. Tomlanovich, M.D.
Stephen J. Tomlanovich, M.D.
Recruiting
Principal Investigator:
Flavio Vincenti, M.D.
Flavio Vincenti, M.D.
Recruiting
Principal Investigator:
Flavio Vincenti, M.D.
Flavio Vincenti, M.D.
Recruiting
Extension Study Of Subjects From Study A3921030 For The Prevention Of Acute Rejection In Kidney Transplant Patients
Study ID: A3921050 LTE
Principal Investigator:
Flavio Vincenti, M.D.
Flavio Vincenti, M.D.
Active, but closed to enrollment
Extension Study Of Subjects From Study A3921030 For The Prevention Of Acute Rejection In Kidney Transplant Patients
Study ID: A3921050 LTE
Principal Investigator:
Flavio Vincenti, M.D.
Flavio Vincenti, M.D.
Active, but closed to enrollment
Extension Study Of Subjects From Study A3921030 For The Prevention Of Acute Rejection In Kidney Transplant Patients
Study ID: A3921050 LTE
Principal Investigator:
Flavio Vincenti, M.D.
Flavio Vincenti, M.D.
Active, but closed to enrollment
Principal Investigator:
Peter Stock M.D., Ph.D
Peter Stock M.D., Ph.D
Recruiting
Principal Investigator:
Peter Stock M.D., Ph.D
Peter Stock M.D., Ph.D
Recruiting
Principal Investigator:
Peter Stock M.D., Ph.D
Peter Stock M.D., Ph.D
Recruiting
Principal Investigator:
Peter Stock M.D., Ph.D
Peter Stock M.D., Ph.D
Recruiting
Principal Investigator:
Peter Stock M.D., Ph.D
Peter Stock M.D., Ph.D
Recruiting
Principal Investigator:
Flavio Vincenti, M.D.
Flavio Vincenti, M.D.
Recruiting
Principal Investigator:
Flavio Vincenti, M.D.
Flavio Vincenti, M.D.
Recruiting
Principal Investigator:
Flavio Vincenti, M.D.
Flavio Vincenti, M.D.
Recruiting
Principal Investigator:
Flavio Vincenti, M.D.
Flavio Vincenti, M.D.
Active, but closed to enrollment
Study of 2 Dose Levels of a JAK3 Inhibitor for the Prevention of Acute Rejection in Kidney Transplant Patients
Study ID: A3921021
Principal Investigator:
Flavio Vincenti, M.D.
Flavio Vincenti, M.D.
Active, but closed to enrollment
Principal Investigator:
Flavio Vincenti, M.D.
Flavio Vincenti, M.D.
Active, but closed to enrollment
Kidney-Focal Segmental Glomerulosclerosis
Safety Study of GC1008 in Patients With Focal Segmental Glomerulosclerosis (FSGS) of Single Doses of GC1008 in Patients With Treatment Resistant Idiopathic FSGS
Study ID: GC1008FSGS00505
Principal Investigator:
Flavio Vincenti, M.D.
Flavio Vincenti, M.D.
Active, but closed to enrollment
Liver Transplant
Efficacy and Safety of Concentration-controlled Everolimus to Eliminate or to Reduce Tacrolimus Compared to Tacrolimus in de Novo Liver Transplant Recipients
Study ID: CRAD001H2304 (RAD)
Principal Investigator:
Sandy Feng, M.D., Ph.D.
Sandy Feng, M.D., Ph.D.
Recruiting
Principal Investigator:
Peter Stock M.D., Ph.D
Peter Stock M.D., Ph.D
Recruiting
Principal Investigator:
Peter Stock M.D., Ph.D
Peter Stock M.D., Ph.D
Recruiting
Principal Investigator:
Peter Stock M.D., Ph.D
Peter Stock M.D., Ph.D
Recruiting
Principal Investigator:
Peter Stock M.D., Ph.D
Peter Stock M.D., Ph.D
Recruiting
Principal Investigator:
Peter Stock M.D., Ph.D
Peter Stock M.D., Ph.D
Recruiting
Principal Investigator:
Flavio Vincenti, M.D.
Flavio Vincenti, M.D.
Recruiting
Principal Investigator:
Flavio Vincenti, M.D.
Flavio Vincenti, M.D.
Recruiting
Principal Investigator:
Flavio Vincenti, M.D.
Flavio Vincenti, M.D.
Recruiting
Lung Transplant
Principal Investigator:
Charles Hoopes, M.D.
Charles Hoopes, M.D.
Recruiting
Mesothelioma
Principal Investigator:
Thierry Jahan, MD
Thierry Jahan, MD
Recruiting
Principal Investigator:
Sarita Dubey, MD
Sarita Dubey, MD
Active, but not currently recruiting
Neuroendocrine Tumors
Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine Tumors
Study ID: UCSF-04458
Principal Investigator:
Emily Bergsland, M.D.
Emily Bergsland, M.D.
Recruiting
Principal Investigator:
Emily Bergsland, M.D.
Emily Bergsland, M.D.
Recruiting
Non-Small Cell Lung Cancer
A First-line Study of IMC-1121B With Paclitaxel and Carboplatin in Stage IIIB/IV Non-small Cell Lung Cancer
Study ID: UCSF-08653
Principal Investigator:
Sarita Dubey, MD
Sarita Dubey, MD
Recruiting
High-Dose or Standard-Dose Radiation Therapy and Chemotherapy in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
Study ID: RTOG-0617
Principal Investigator:
Mack Roach III M.D., F.A.C.R.
Mack Roach III M.D., F.A.C.R.
Recruiting
PF-00299804 As a Single Oral Agent In Untreated Adenocarcinoma Of The Lung In Non-Smokers Or Former Light Smokers
Study ID: A7471017
Principal Investigator:
Sarita Dubey, MD
Sarita Dubey, MD
Recruiting
RADIANT: A Study of Tarceva After Surgery With or Without Adjuvant Chemotherapy in NSCLC Patients Who Have EGFR-positive Tumors
Study ID: OSI-774-302
Principal Investigator:
Sarita Dubey, MD
Sarita Dubey, MD
Recruiting
Obesity
Insulin Sensitivity after Gastric Bypass, Adjustable Gastric Banding and Caloric Restriction in Persons With Morbid Obesity: A Stratified, Randomized, Controlled Pilot Trial.
Study ID: UCSF-H49493-28734
Principal Investigator:
Guilherme Campos, M.D., Ph.D.
Guilherme Campos, M.D., Ph.D.
Active, but not currently recruiting
Principal Investigator:
Stanley J. Rogers, M.D.
Stanley J. Rogers, M.D.
Active, but not currently recruiting
Pancreatic Cancer
Gemcitabine and Capecitabine to Treat Patients With Advanced Pancreatic and Biliary Cancers
Study ID: UCSF-074510
Principal Investigator:
Andrew H. Ko, M.D.
Andrew H. Ko, M.D.
Recruiting
Gemcitabine and S-1 for Locally Advanced Unresectable or Metastatic Pancreatic Cancer
Study ID: UCSF-06456
Principal Investigator:
Andrew H. Ko, M.D.
Andrew H. Ko, M.D.
Recruiting
Principal Investigator:
Andrew H. Ko, M.D.
Andrew H. Ko, M.D.
Active, but not currently recruiting
Peripheral Artery Disease
Principal Investigator:
Christopher D. Owens, M.D., MSc
Christopher D. Owens, M.D., MSc
Recruiting
Principal Investigator:
Roberta K. Oka, A.N.P., D.NSc.
Roberta K. Oka, A.N.P., D.NSc.
Recruiting
Use of Vascular Repair Cells (VRC) in Patients With Peripheral Arterial Disease to Treat Critical Limb Ischemia
Study ID: H9146-31071
Principal Investigator:
Darren Schneider, M.D.
Darren Schneider, M.D.
Recruiting
Rectal Cancer
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
Study ID: CALGB-C80405
Principal Investigator:
Alan P. Venook, M.D.
Alan P. Venook, M.D.
Recruiting
Radiation Therapy and Fluorouracil With or Without Combination Chemotherapy Followed by Surgery in Treating Patients With Stage II or Stage III Rectal Cancer
Study ID: UCSF-03451
Principal Investigator:
Madhulika Varma, M.D.
Madhulika Varma, M.D.
Recruiting
Small Cell Lung Cancer
Sunitinib, Cisplatin or Carboplatin, and Etoposide in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Study ID: CALGB-30504
Principal Investigator:
Sarita Dubey, MD
Sarita Dubey, MD
Active, but not currently recruiting
Solid Tumor
A Phase 1 Dose-escalation Study of a Cell Cycle Inhibitor With and Without Gemcitabine in Patients With Solid Tumors or Lymphoma (Study P05248AM2)
Study ID: UCSF-08991
Principal Investigator:
Adil Daud, M.D.
Adil Daud, M.D.
Recruiting
A Study of R1507 in Combination With Multiple Standard Chemotherapy Treatments in Patients With Advanced Solid Tumors
Study ID: UCSF-08994
Principal Investigator:
Pamela Munster, M.D.
Pamela Munster, M.D.
Recruiting
Imatinib Mesylate, Bevacizumab, and Cyclophosphamide in Treating Patients With Refractory Metastatic Solid Tumors
Study ID: UCSF-06991
Principal Investigator:
Emily Bergsland, M.D.
Emily Bergsland, M.D.
Suspended
Panobinostat and Epirubicin in Treating Patients With Metastatic Malignant Solid Tumors
Study ID: UCSF-09991
Principal Investigator:
Pamela Munster, M.D.
Pamela Munster, M.D.
Recruiting
Thoracic Aneurysms
A Clinical Study of the Safety and Efficacy of the Relay Thoracic Stent-Graft in Patients With Thoracic Aortic Pathologies
Study ID: H9065-30421
Principal Investigator:
Timothy A.M. Chuter, M.D.
Timothy A.M. Chuter, M.D.
Recruiting
Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm
Study ID: H5357-26067
Principal Investigator:
Linda M. Reilly, M.D.
Linda M. Reilly, M.D.
Recruiting
Evaluation of the GORE TAG Thoracic Endoprosthesis in the Treatment of Aneurysms
Study ID: H9146-28715
Principal Investigator:
Darren Schneider, M.D.
Darren Schneider, M.D.
Active, but closed to enrollment
STARZ-TX2 Clinical Study: Study of Thoracic Aortic Aneurysm Repair With the Zenith TX2 Endovascular Graft
Study ID: 03-536
Principal Investigator:
Darren Schneider, M.D.
Darren Schneider, M.D.
Active, but closed to enrollment
STARZ-TX2 Clinical Study: Study of Thoracic Aortic Aneurysm Repair With the Zenith TX2 Endovascular Graft
Study ID: 03-536
Principal Investigator:
Darren Schneider, M.D.
Darren Schneider, M.D.
Active, but closed to enrollment